TABLE 1.
Overview of the Evidence on Associations Between CGM-Derived Parameters of Glycemic Control and Patient-Reported Outcomes
| Type of Analysis | Type of Evidence | Limitations | |
|---|---|---|---|
| Interventional studies | • Randomized controlled trials on the efficacy of CGM and AID systems • Congruent improvements of CGM-derived parameters of glycemic control and PROs, indicative of an association |
• Large effect sizes regarding improvement of CGM-derived parameters • Small to medium effect sizes regarding improvement of PROs |
• No direct analysis of associations • Rather optimal baseline levels of PRO measures, possible lack of room for improvement |
| Observational studies | • Direct analysis of the association between CGM-derived parameters and PROs | • Higher TIR associated with better mood • Higher mean glucose/more TAR associated with negative affect/anger |
• Rather small sample sizes • No causality |
| Ongoing studies | • Using EMA and CGM to analyze immediate effects of CGM-derived parameters on PROs and vice versa | • Planned: real-time effects of glucose on PROs and vice versa • Planned: intraindividual patterns |
• Publications in peer-reviewed journals pending |